ShinMineishiMD

Oncology • Hershey, PA

Hematologic Oncology

Professor and Director, Blood and Marrow Transplant Penn State Hershey Medical Center

Join to view full profile

Dr. Mineishi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mineishi's full profile

Already have an account?

Office
500 University Dr
Hershey, PA 17033
Phone+1 717-531-8678

Fax+1 717-531-5111

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1991 - 1995
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1988 - 1991
Graduate School of Medicine and Faculty of Medicine, The University of TokyoClass of 1984

Certifications & Licensure

PA State Medical License 2016 - 2024
AL State Medical License 2012 - 2016
MI State Medical License 2005 - 2015
TN State Medical License 2003 - 2006
WI State Medical License 1996 - 2001

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401) Start of enrollment: 2005 Dec 01
Completed
Phase 3
Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) Start of enrollment: 2010 May 01
Completed
Phase 3
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen Start of enrollment: 2011 Nov 01
Completed
Phase 2
Double Cord Versus Haploidentical (BMT CTN 1101) Start of enrollment: 2012 Jun 01
Completed
Phase 3
Fludarabine / Total Body Irradiation Regimen for ALLO HCT in Acute Lymphoblastic Leukemia Start of enrollment: 2013 Aug 27
Completed
Phase 2
Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis Start of enrollment: 2013 Aug 27
Completed
Phase 2
Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT) Start of enrollment: 2014 Oct 09
Completed
Not Applicable
Pevonedistat and Azacitidine as Maintenance Therapy After Allogeneic Stem Cell Transplantation for Non-Remission AML Start of enrollment: 2018 Jul 18
Terminated
Phase 2
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Roles: Contact, Principal Investigator
A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002) Start of enrollment: 2022 Jun 16
Terminated
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

615 citations
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
Claudio Anasetti, Brent R. Logan, Stephanie J. Lee, Edmund K. Waller, Daniel J. Weisdorf
The New England Journal of Medicine. 2012-10-18
326 citations
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
Keith M. Sullivan, Ellen Goldmuntz, Lynette Keyes-Elstein, Peter A. McSweeney, Ashley Pinckney
The New England Journal of Medicine. 2018-01-03
621 citations
A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.
James L. Abbruzzese, R Grunewald, E A Weeks, D Gravel, T Adams
Journal of Clinical Oncology. 1991-03-01

Journal Articles

Clofarabine Followed by Haploidentical Stem Cell Transplant Using Fludarabine, Busulfan, and Total-Body Irradiation with Post-Transplant Cyclophosphamide in Non-Remiss...
Shin Mineishi, David Claxton, Kevin Rakszawski, Hiroko Shike, International Journal of Hematology
Safety of Repeated Un-Manipulated Peripheral Blood Stem Cell Haploidentical Transplant for Graft Failure
N Patil, D Salzman, J H Chewning, L Lamb, S Mineishi, Nature

Abstracts/Posters

Graft-Versus-Host Disease Causes the Failure of Donor Hematopoietic Progenitor Cells to Reconstitute Plasmacytoid Dendritic Cells That Promote Tolerance of Donor T Cel...
Shin Mineishi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Impact of Renal Dysfunction Measured By Estimated Glomerular Filtration Rate (eGFR) on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)
Shin Mineishi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

The Nats’ Doug Harris Beat Cancer Three Times. His Fourth Battle Is During a PandemicJanuary 4th, 2020
It's Her 'Day Zero' -- the Day Her Brother Gave Her New LifeApril 24th, 2017